HIGHLIGHTS
- who: October and colleagues from the Wayne State University, United States have published the research: Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18 - glycyrrhetinic acid against non-small cell lung cancer, in the Journal: (JOURNAL)
- what: The authors aimed to unveil the mechanism of action and the molecular pathways affected by 18u03b1-GA against NSCLC by network pharmacology, which was further corroborated by molecular docking studies, and the core target genes were identified. The experiment was performed as described previously (Padder et_al, 2021). This study has first time delineated the anti . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.